Tempest Therapeutics, Inc. (TPST)
TPST Stock Price Chart
Explore Tempest Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TPST price movements and trends.
TPST Company Profile
Discover essential business fundamentals and corporate details for Tempest Therapeutics, Inc. (TPST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Nov 2012
Employees
24.00
Website
https://www.tempesttx.comCEO
Matthew Angel
Description
Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for its role in regulating the innate immune response within cancerous growths. Established in 2011, Tempest Therapeutics Inc. is headquartered in South San Francisco, California, having previously operated as a subsidiary of Inception Sciences, Inc.
TPST Financial Timeline
Browse a chronological timeline of Tempest Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Aug 2026
EPS estimate is -$0.30.
Earnings released on 14 May 2026
EPS came in at -$2.53 falling short of the estimated -$0.28 by -803.57%.
Earnings released on 31 Mar 2026
EPS came in at -$0.62 matching the estimated -$0.62.
Earnings released on 5 Nov 2025
EPS came in at -$0.79 surpassing the estimated -$3.27 by +75.84%.
Earnings released on 11 Aug 2025
EPS came in at -$2.07 surpassing the estimated -$3.23 by +35.91%.
Earnings released on 13 May 2025
EPS came in at -$3.16 surpassing the estimated -$3.71 by +14.82%.
Stock split effective on 9 Apr 2025
Shares were split 1 : 13 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Mar 2025
EPS came in at -$4.03 falling short of the estimated -$3.12 by -29.17%.
Earnings released on 12 Nov 2024
EPS came in at -$5.33 falling short of the estimated -$4.81 by -10.81%.
Earnings released on 8 Aug 2024
EPS came in at -$5.46 surpassing the estimated -$6.11 by +10.64%.
Earnings released on 9 May 2024
EPS came in at -$4.68 surpassing the estimated -$5.72 by +18.18%.
Earnings released on 19 Mar 2024
EPS came in at -$4.42 surpassing the estimated -$4.94 by +10.53%.
Earnings released on 8 Nov 2023
EPS came in at -$6.24 surpassing the estimated -$7.15 by +12.73%.
Earnings released on 10 Aug 2023
EPS came in at -$7.02 surpassing the estimated -$7.54 by +6.90%.
Earnings released on 10 May 2023
EPS came in at -$7.15 surpassing the estimated -$8.58 by +16.67%.
Earnings released on 22 Mar 2023
EPS came in at -$8.19 surpassing the estimated -$9.36 by +12.50%.
Earnings released on 8 Nov 2022
EPS came in at -$8.58 surpassing the estimated -$9.88 by +13.16%.
Earnings released on 15 Aug 2022
EPS came in at -$10.27 surpassing the estimated -$11.96 by +14.13%.
Earnings released on 13 May 2022
EPS came in at -$15.34 falling short of the estimated -$14.56 by -5.36%.
Earnings released on 29 Mar 2022
EPS came in at -$1.12 surpassing the estimated -$1.23 by +8.94%.
Earnings released on 10 Nov 2021
EPS came in at -$15.73 falling short of the estimated -$13.65 by -15.24%.
Earnings released on 12 Aug 2021
EPS came in at -$99.22 falling short of the estimated -$11.44 by -767.31%.
TPST Stock Performance
Access detailed TPST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
